* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-01 | Tetracosactide Acetate | 2933.5 | C136H210N40O31S | Inquiry |
10-101-02 | Alarelin acetate | 1287.44 | C60H86N16O16 | Inquiry |
10-101-03 | Angiotensin II Acetate | 1106.2 | C52H75N13O14 | Inquiry |
10-101-05 | Atosiban | 994.19 | C43H67N11O12S2 | Inquiry |
10-101-06 | Bivalirudin Trifluoroacetate | 2180.32 | C98H138N24O33 | Inquiry |
10-101-07 | Buserelin Acetate | 1299.48 | C62H90N16O15 | Inquiry |
10-101-10 | Deslorelin Acetate | 1342.5 | C66H87N17O14 | Inquiry |
10-101-100 | Thymosin β15 | 5285.05 | C225H377N59O80S3 | Inquiry |
10-101-101 | Triptorelin Pamoate | 1744.96 | C64H82N18O13 | Inquiry |
10-101-102 | Depreotide | 1357.69 | C65H96N16O12S2 | Inquiry |
10-101-103 | Vancomycin | 1449.25 | C66H75Cl2N9O24 | Inquiry |
10-101-104 | Teicoplanin | 1879.66 | C88H95Cl2N9O33 | Inquiry |
10-101-105 | Ramoplanin | 2254.06 | C106H170ClN21O30 | Inquiry |
10-101-106 | Acetylcysteine Ph. Eur. | 163.2 | C5H9NO3S | Inquiry |
10-101-107 | Adefovir Dipivoxil | 501.48 | C20H32N5O8P | Inquiry |
10-101-108 | Antazoline Hydrochloride Ph. Eur. | 265.36 (net), 301.82 (hydrochloride) | C17H20ClN3 | Inquiry |
10-101-109 | Antazoline Phosphate | 265.36 (net), 363.35 (phosphate) | C17H22N3O4P | Inquiry |
10-101-110 | Antazoline Sulfate | 363.35 | C17H19N3·H2O4S | Inquiry |
10-101-111 | Atomoxetine Hydrochloride | 291.82 | C17H21NO · HCl | Inquiry |
10-101-112 | Bremelanotide | 1025.18 | C50H68N14O10 | Inquiry |
Creative Peptides is the world's first-choice supplier of peptides used as pharmaceutical agents with a range of more than 100 peptides and related products, from grams to kgs, generic standard to cGMP (current Good Manufacturing Practice) standard. As a reliable partner for APIs manufacture, we have served a great many of customers by providing qualified APIs for their projects. Now they are broadly used in the fields of cancer, cardiovascular and diabetes research, etc.
APIs are also known as bulk pharmaceuticals, and the peptides used as APIs take a special vital role in the pharmaceutical industry. Only the good management of API peptides synthesis can better serve the pharmaceutical industry as well as the human health.
From these approaches, there are two general strategies to prepare a peptide: through chemical synthesis or the application of biological methods. A combination of these two general strategies could also be applied in some cases.
Approach | Scale | Peptide length | Process development | Cost of process |
Solution-phrase synthesis | Gram to kilogram to ton | Short peptides | Long | Relatively expensive |
Solid-phrase synthesis | Milligram to gram to kilogram | Medium to long peptides | Rapid | Expensive |
Hybrid synthesis | Gram to kilogram to ton | Long peptides and proteins | Rapid | Expensive |
Native isolation | Gram to kilogram | Long peptides and proteins | Long | Expensive |
Enzymatic synthesis | Gram to kilogram to ton | Short peptides | Long | Relatively expensive |
Recombinant DNA | Gram to kilogram to ton | Long peptides and proteins | Long | Inexpensive |
Semi-synthesis | Gram to kilogram to ton | Long peptides and proteins | Very long | Relatively expensive |
Several techniques are available for the purification of peptides. Among them, crystallization, gel chromatography, ion-exchange chromatography, low pressure hydrophobic interaction chromatography, countercurrent distribution, partition chromatography and RP-HPLC are the most popular for the industrial purification of peptides. However, crystallization is the first-choice technique due to its low cost, but it is difficult to apply to peptides containing more than four to five residues, because longer peptides are generally difficult to crystallize. For the isolation of longer peptides, precipitation is sometimes successfully applied.
In 2013, the US Pharmacopeia (USP) Therapeutic Peptides Expert Panel was established to assess quality attributes for synthetic peptide APIs based on currently available regulatory direction and expectations. According to the panel explores the current manufacturing and regulatory landscape bring out three articles as below. These articles provide a comprehensive overview of quality attributes to be considered for successful synthetic peptide APIs development from manufacturing to lot release.
USP hopes that the work of the Therapeutic Peptides Expert Panel and those articles can offer more constant management to help support efforts to create a maintainable platform for the development of peptide-based drugs.
With years of extensive experience on APIs manufacture, Creative Peptides is able to provide comprehensive support for all stages of APIs development and production. With the advanced technologies and innovative methodologies, your unique requirement can be satisfied. Below is a list of the API peptides we are currently offering. If you have any request for API peptides synthesis, please feel free to contact us. Our sales team will generate a quote for you with price and delivery time at their first available moment.
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
PAC-113, as well as a new type of Trp-rich peptide, is a 12 amino-acid fragment of the saliva protein histatin 5 ...
Guangxitoxin 1E is a KV2.1 and KV2.2 specific channel blocker (IC50 values are 1-3 nM). The experimental results ...
The thymopentin is a small peptide consisting of 5 amino acid residues (Arg-Lys-Asp-Val-Tyr) from thymosin. It h ...
Purotoxin 1, a component from the venom of Geolycosa spiders, exerts selective inhibitory action on P2X3 recep ...
(d(CH2)51,Tyr(Me)2,Arg8)-vasopressin, a kind of vasopressin, is a prohormone in neurons in the hypothalamus. Vas ...